Trial Profile
Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Dec 2023
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Depression
- Focus Therapeutic Use
- Acronyms EPO-T
- 20 Dec 2023 Results assessing the effects of four add-on erythropoietin or saline in severely depressed patients with unipolar or bipolar depression, published in the European Neuropsychopharmacology.
- 13 Feb 2023 Status changed from recruiting to completed.
- 17 Aug 2022 Planned End Date changed from 31 Dec 2020 to 30 Sep 2023.